Let's analyze the nature and function of α-1 antitrypsin (AAT):
Now let's evaluate the options:
Therefore, α-1 antitrypsin is used to treat emphysema (associated with its deficiency).
α-1 antitrypsin is a protein produced in the liver and released into the bloodstream. It plays a crucial role in protecting the lungs by inhibiting an enzyme called neutrophil elastase, which can damage alveoli (air sacs) in the lungs if not properly controlled.
In α-1 antitrypsin deficiency, this protective protein is lacking or defective, leading to unchecked activity of neutrophil elastase, which damages lung tissue and can cause a condition called emphysema, a chronic obstructive pulmonary disease (COPD).
Therapeutic use:
α-1 antitrypsin is used as a treatment for emphysema caused by its deficiency. This therapy involves intravenous infusions of purified α-1 antitrypsin to restore its levels in the blood and protect the lungs.
Correct Answer: used to treat emphysema
Read the following passage and answer the questions that follow. Prevention is the frontline response to drug use. Effective interventions address the underlying conditions contributing to drug use, such as a lack of connection to family or community, instability, insecurity, trauma, mental health issues, etc. When addressed, these factors can effectively prevent the initiation of drug use and the progression to drug use disorders. Study the few key figures of drug use given below and answer the questions that follow.
(a) What do you infer from the figures in Table No. 1 about the people with drug use disorders, 2022 (in million)? State any two of your observations.
(b) How are Hepatitis C and HIV related to drug use disorders by people, as shown in Table No. 2? State the correlation between the two.
(c)